Outpatient parenteral antibiotic therapy: principles and practice
- PMID: 23602223
- DOI: 10.1016/j.ejim.2013.03.014
Outpatient parenteral antibiotic therapy: principles and practice
Abstract
Outpatient parenteral antimicrobial therapy (OPAT) refers to the administration of a parenteral antimicrobial in a non inpatient or ambulatory setting with the explicit aim of facilitating admission avoidance or early discharge. Whilst OPAT has predominantly been the domain of the infection specialist, the internal medicine specialist has a key role in service development and delivery as a component of broader ambulatory care initiatives such as "hospital at home". Main drivers for OPAT are patient welfare, reduction of risk of health care associated infection and cost-effective use of hospital resources. The safe practice of OPAT is dependent on a team approach with careful patient selection and antimicrobial management with programmed and adaptable clinical monitoring and assessment of outcome. Gram-positive infections, including cellulitis, bone and joint infection, bacteraemia and endocarditis are key infections potentially amenable to OPAT whilst resistant Gram-negative infections are of increasing importance. Ceftriaxone, teicoplanin, daptomycin and ertapenem lend themselves well to OPAT due to daily (or less frequent) bolus administration, although any antimicrobial may be administered if the patient is trained to administer and/or an appropriate infusion device is employed. Clinical experience from NHS Greater Glasgow and Clyde is presented to illustrate the key principles of OPAT as practised in the UK. Increasingly complex patients with multiple medical needs, the relative scarcity of inpatient resources and the broader challenge of ambulatory care and "hospital at home" will ensure the internal medicine specialist will have a key role in the future development of OPAT.
Keywords: Ambulatory care; Bone and joint infection; Cellulitis; Endocarditis; Hospital at home.
Copyright © 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Similar articles
-
[Outpatient parenteral antibiotic therapy (OPAT)].Cas Lek Cesk. 2016;155(3):21-4. Cas Lek Cesk. 2016. PMID: 27256144 Review. Czech.
-
[Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].Med Mal Infect. 2006 Mar;36(3):132-7. doi: 10.1016/j.medmal.2006.01.002. Epub 2006 Mar 31. Med Mal Infect. 2006. PMID: 16580802 Review. French.
-
Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.J Antimicrob Chemother. 2009 Sep;64(3):447-53. doi: 10.1093/jac/dkp245. Epub 2009 Jul 7. J Antimicrob Chemother. 2009. PMID: 19584105 Review.
-
Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.J Antimicrob Chemother. 2007 Aug;60(2):356-62. doi: 10.1093/jac/dkm210. Epub 2007 Jun 11. J Antimicrob Chemother. 2007. PMID: 17566002
-
Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.Enferm Infecc Microbiol Clin. 2011 Oct;29(8):587-92. doi: 10.1016/j.eimc.2011.05.007. Epub 2011 Jun 30. Enferm Infecc Microbiol Clin. 2011. PMID: 21723004 Clinical Trial.
Cited by
-
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177. J Antimicrob Chemother. 2024. PMID: 38842523 Free PMC article. Review.
-
[Outpatient parenteral anti-infective therapy (OPAT)].Inn Med (Heidelb). 2024 Jun;65(6):566-575. doi: 10.1007/s00108-024-01707-1. Epub 2024 May 14. Inn Med (Heidelb). 2024. PMID: 38743073 German.
-
Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study.Infection. 2024 Aug;52(4):1407-1414. doi: 10.1007/s15010-024-02199-9. Epub 2024 Mar 13. Infection. 2024. PMID: 38478255 Free PMC article.
-
Factors associated with loss to follow-up in outpatient parenteral antimicrobial therapy: A retrospective cohort study.Infect Control Hosp Epidemiol. 2024 Mar;45(3):387-389. doi: 10.1017/ice.2023.216. Epub 2023 Oct 2. Infect Control Hosp Epidemiol. 2024. PMID: 37782035 Free PMC article.
-
Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy.Pharmaceutics. 2023 Aug 8;15(8):2099. doi: 10.3390/pharmaceutics15082099. Pharmaceutics. 2023. PMID: 37631313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
